Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADIAL
2022-500449-26-00Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
Phase 4, randomised, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Time to enrolment, Study completion proportion and 3 more. Started Nov 2022; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2022-500449-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500449-26-00.